We outline the market outlook for nature mining in the life sciences industry — from investment trends and leading companies to recommendations for the players in the space.
What is nature mining?
Nature mining uses biological data from natural sources — such as fungi, microbes, and plants — to discover novel drug candidates. Platforms typically collect data through genome sequencing and/or manually cataloging molecules produced by the organism. Then, they apply machine learning (ML) to parse the data and uncover drug candidates.
Features & capabilities
Nature mining provides pharma and contract research organization (CRO) leaders with several capabilities, including the following:
- Computational platforms
- Enabled ML-driven approaches
- Advanced statistics and automation
- Speedy discovery of novel solutions
- High-throughput screening
Benefits
Nature mining offers these substantial benefits to pharma and CRO leaders:
- Reduce global reliance on antibiotics for infant health
- Improved health benefit quality
- Validated preclinical and clinical studies
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
